Lipid Nanoparticles as Carriers for RNAi against Viral Infections: Current Status and Future Perspectives

The efforts made to develop RNAi-based therapies have led to productive research in the field of infections in humans, such as hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), human cytomegalovirus (HCMV), herpetic keratitis, human papillomavirus, or influenza vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Torrecilla, Josune, Rodríguez-Gascón, Alicia, Solinís, María Ángeles, del Pozo-Rodríguez, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145386/
https://www.ncbi.nlm.nih.gov/pubmed/25184135
http://dx.doi.org/10.1155/2014/161794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145386/
https://www.ncbi.nlm.nih.gov/pubmed/25184135
http://dx.doi.org/10.1155/2014/161794

Ejemplares similares